BlackRock Investment Management, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 67 filers reported holding IMMUNE DESIGN CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$304,000
-24.6%
55,251
+3.9%
0.00%
Q3 2016$403,000
+17.8%
53,161
+26.9%
0.00%
Q2 2016$342,000
-33.5%
41,876
+6.0%
0.00%
-100.0%
Q1 2016$514,000
-34.1%
39,511
+1.7%
0.00%0.0%
Q4 2015$780,000
+64.9%
38,857
+0.2%
0.00%0.0%
Q3 2015$473,000
-50.1%
38,788
-15.5%
0.00%0.0%
Q2 2015$948,000
+148.8%
45,901
+154.5%
0.00%
Q1 2015$381,000
-29.6%
18,039
+2.6%
0.00%
-100.0%
Q4 2014$541,000
+115.5%
17,579
+23.8%
0.00%
Q3 2014$251,00014,2050.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$16,016,0006.52%
Abingworth LLP 197,300$1,610,0001.69%
NEXTHERA CAPITAL LP 85,138$695,0000.60%
Cormorant Asset Management, LP 432,990$3,533,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 153,000$1,248,0000.32%
TFS CAPITAL LLC 102,685$838,0000.15%
RS INVESTMENT MANAGEMENT CO LLC 1,227,595$10,017,0000.10%
Eventide Asset Management 180,000$1,469,0000.09%
Focused Wealth Management, Inc 15,868$129,0000.06%
Spark Investment Management LLC 77,500$632,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders